Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Sleeboom

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
International Journal of Cancer|May 28, 1992
Pharmacodynamics and pharmacokinetics of intravesical mitomycin C upon different dwelling timesE A De Bruijn, H P Sleeboom, P J van Helsdingen, et al.
The American Journal of Medicine|June 1, 1987
Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chlorideH I Harinck, O L Bijvoet, A S Plantingh, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?A T van Holten-Verzantvoort, J Hermans, L V Beex, et al.
Immunology|September 1, 1982
In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferationE de Vries, J P van der Weij, C J van der Veen, et al.
British Journal of Cancer|January 26, 2005
A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinomaJ J Arends, H P Sleeboom, M B L Leys, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Palliative pamidronate treatment in patients with bone metastases from breast cancerA T van Holten-Verzantvoort, H M Kroon, O L Bijvoet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 11, 2012
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsR Coleman, R de Boer, H Eidtmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer GroupH Mouridsen, M Gershanovich, Y Sun, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Cancer|May 28, 1992
Pharmacodynamics and pharmacokinetics of intravesical mitomycin C upon different dwelling timesE A De Bruijn, H P Sleeboom, P J van Helsdingen, et al.
The American Journal of Medicine|June 1, 1987
Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chlorideH I Harinck, O L Bijvoet, A S Plantingh, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?A T van Holten-Verzantvoort, J Hermans, L V Beex, et al.
Immunology|September 1, 1982
In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferationE de Vries, J P van der Weij, C J van der Veen, et al.
British Journal of Cancer|January 26, 2005
A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinomaJ J Arends, H P Sleeboom, M B L Leys, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Palliative pamidronate treatment in patients with bone metastases from breast cancerA T van Holten-Verzantvoort, H M Kroon, O L Bijvoet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 11, 2012
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsR Coleman, R de Boer, H Eidtmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer GroupH Mouridsen, M Gershanovich, Y Sun, et al.
Pageof 2